These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17786064)

  • 1. Risk of anticoagulation for atrial fibrillation in the elderly.
    DeSilvey DL
    Am J Geriatr Cardiol; 2007; 16(5):325-6. PubMed ID: 17786064
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleeding risk on warfarin among elderly patients with atrial fibrillation.
    Cowan A; Hylek EM
    J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052
    [No Abstract]   [Full Text] [Related]  

  • 3. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 4. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 5. Good old warfarin for stroke prevention in atrial fibrillation.
    Verheugt FW
    Lancet; 2006 Jun; 367(9526):1877-8. PubMed ID: 16765740
    [No Abstract]   [Full Text] [Related]  

  • 6. Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P; Homma S
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation: stroke prevention in older adults.
    Quinn GR; Fang MC
    Clin Geriatr Med; 2012 Nov; 28(4):617-34. PubMed ID: 23101573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anticoagulants offer options beyond warfarin to reduce stroke risk.
    Mitka M
    JAMA; 2012 Nov; 308(17):1727-8. PubMed ID: 23117757
    [No Abstract]   [Full Text] [Related]  

  • 9. Stroke prevention in elderly patients with atrial fibrillation.
    Garcia D; Hylek E
    Lancet; 2007 Aug; 370(9586):460-1. PubMed ID: 17693158
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 12. Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.
    Lane DA; Lip GY
    Stroke; 2008 Jan; 39(1):7-9. PubMed ID: 18048849
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulation in the elderly.
    Henderson MC; White RH
    Curr Opin Pulm Med; 2001 Sep; 7(5):365-70. PubMed ID: 11584191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
    Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
    Wong CW
    Hong Kong Med J; 2016 Dec; 22(6):608-15. PubMed ID: 27920399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation.
    Zoppellaro G; Granziera S; Bertozzo G; Denas G; Marigo L; Petruzzellis F; Padayattil Jose S; Rossi K; Nante G; Pengo V
    Thromb Haemost; 2017 Aug; 117(9):1828-1830. PubMed ID: 28726972
    [No Abstract]   [Full Text] [Related]  

  • 17. Bleeding risk factors affecting warfarin therapy in the elderly with atrial fibrillation.
    Darnell SW; Davis SC; Whitcomb JJ; Manfredi JA; McLaurin BT
    Dimens Crit Care Nurs; 2014; 33(2):57-63. PubMed ID: 24496251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
    Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.